{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:34:20Z","timestamp":1790408060695,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-023-02052-x","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T12:01:25Z","timestamp":1687003285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in \u201cextreme\u201d neurosurgical conditions"],"prefix":"10.1007","volume":"46","author":[{"given":"Alexandre","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumaima","family":"Aboubakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Moiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Benevello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssem","family":"Fathallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Parraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Chretien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Dezamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Pallud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"key":"2052_CR1","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1002\/cncr.24398","volume":"115","author":"ML Affronti","year":"2009","unstructured":"Affronti ML, Heery CR, Herndon JE, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS (2009) Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer 115:3501\u20133511. https:\/\/doi.org\/10.1002\/cncr.24398","journal-title":"Cancer"},{"key":"2052_CR2","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/neuonc\/nou349","volume":"17","author":"SA Almenawer","year":"2015","unstructured":"Almenawer SA, Badhiwala JH, Alhazzani W, Greenspoon J, Farrokhyar F, Yarascavitch B, Algird A, Kachur E, Cenic A, Sharieff W, Klurfan P, Gunnarsson T, Ajani O, Reddy K, Singh SK, Murty NK (2015) Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. Neuro-Oncol 17:868\u2013881. https:\/\/doi.org\/10.1093\/neuonc\/nou349","journal-title":"Neuro-Oncol"},{"key":"2052_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2176\/nmc.oa2013-0112","volume":"54","author":"T Aoki","year":"2014","unstructured":"Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, Kawabata N, Mishima K, Adachi J, Kurisu K, Yamasaki F, Tominaga T, Kumabe T, Ueki K, Higuchi F, Yamamoto T, Ishikawa E, Takeshima H, Yamashita S, Arita K, Hirano H, Yamada S, Matsutani M, NPC-08 study group (2014) A multicenter phase I\/II study of the BCNU implant (Gliadel(\u00ae) Wafer) for Japanese patients with malignant gliomas. Neurol Med Chir (Tokyo) 54:290\u2013301","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2052_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12957-016-0975-5","volume":"14","author":"LS Ashby","year":"2016","unstructured":"Ashby LS, Smith KA, Stea B (2016) Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. World J Surg Oncol 14:225. https:\/\/doi.org\/10.1186\/s12957-016-0975-5","journal-title":"World J Surg Oncol"},{"key":"2052_CR5","doi-asserted-by":"publisher","first-page":"20170271","DOI":"10.1259\/bjr.20170271","volume":"91","author":"A Asmaa","year":"2018","unstructured":"Asmaa A, Dixit S, Rowland-Hill C, Achawal S, Rajaraman C, O\u2019Reilly G, Highley R, Hussain M, Baker L, Gill L, Morris H, Hingorani M (2018) Management of elderly patients with glioblastoma-multiforme \u2013 a systematic review. Br J Radiol 91:20170271. https:\/\/doi.org\/10.1259\/bjr.20170271","journal-title":"Br J Radiol"},{"key":"2052_CR6","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1245\/s10434-008-0048-2","volume":"15","author":"FJ Attenello","year":"2008","unstructured":"Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H (2008) Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol 15:2887\u20132893. https:\/\/doi.org\/10.1245\/s10434-008-0048-2","journal-title":"Ann Surg Oncol"},{"key":"2052_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3109\/02688697.2012.697221","volume":"26","author":"JG Barr","year":"2012","unstructured":"Barr JG, Grundy PL (2012) The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma. Br J Neurosurg 26:818\u2013822. https:\/\/doi.org\/10.3109\/02688697.2012.697221","journal-title":"Br J Neurosurg"},{"key":"2052_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12883-021-02424-0","volume":"21","author":"M Barz","year":"2021","unstructured":"Barz M, Gerhardt J, Bette S, Aftahy AK, Huber T, Combs SE, Ryang Y-M, Wiestler B, Skardelly M, Gepfner-Tuma I, Behling F, Schmidt-Graf F, Meyer B, Gempt J (2021) Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale \u2013 a bicentric retrospective study. BMC Neurol 21:446. https:\/\/doi.org\/10.1186\/s12883-021-02424-0","journal-title":"BMC Neurol"},{"key":"2052_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","volume":"136","author":"DJ Brat","year":"2018","unstructured":"Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV.\u201d Acta Neuropathol (Berl) 136:805\u2013810. https:\/\/doi.org\/10.1007\/s00401-018-1913-0","journal-title":"Acta Neuropathol (Berl)"},{"key":"2052_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet Lond Engl 345:1008\u20131012","journal-title":"Lancet Lond Engl"},{"key":"2052_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jocn.2012.07.016","volume":"20","author":"KL Chaichana","year":"2013","unstructured":"Chaichana KL, Martinez-Gutierrez JC, De la Garza-Ramos R, Weingart JD, Olivi A, Gallia GL, Lim M, Brem H, Quinones-Hinojosa A (2013) Factors associated with survival for patients with glioblastoma with poor pre-operative functional status. J Clin Neurosci Off J Neurosurg Soc Australas 20:818\u2013823. https:\/\/doi.org\/10.1016\/j.jocn.2012.07.016","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"2052_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1179\/1743132811Y.0000000006","volume":"33","author":"KL Chaichana","year":"2011","unstructured":"Chaichana KL, Zaidi H, Pendleton C, McGirt MJ, Grossman R, Weingart JD, Olivi A, Qui\u00f1ones-Hinojosa A, Brem H (2011) The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival. Neurol Res 33:759\u2013764. https:\/\/doi.org\/10.1179\/1743132811Y.0000000006","journal-title":"Neurol Res"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-020-03410-1","volume":"147","author":"C Champeaux","year":"2020","unstructured":"Champeaux C, Weller J (2020) Implantation of carmustine wafers (Gliadel\u00ae) for high-grade glioma treatment. A 9-year nationwide retrospective study. J Neurooncol 147:159\u2013169. https:\/\/doi.org\/10.1007\/s11060-020-03410-1","journal-title":"J Neurooncol"},{"key":"2052_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-015-1724-2","volume":"122","author":"SA Chowdhary","year":"2015","unstructured":"Chowdhary SA, Ryken T, Newton HB (2015) Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis. J Neurooncol 122:367\u2013382. https:\/\/doi.org\/10.1007\/s11060-015-1724-2","journal-title":"J Neurooncol"},{"key":"2052_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-016-2318-3","author":"A Darlix","year":"2016","unstructured":"Darlix A, Zouaoui S, Rigau V, Bessaoud F, Figarella-Branger D, Mathieu-Daud\u00e9 H, Tr\u00e9tarre B, Bauchet F, Duffau H, Taillandier L, Bauchet L (2016) Epidemiology for primary brain tumors: a nationwide population-based study. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-016-2318-3","journal-title":"J Neurooncol"},{"key":"2052_CR16","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00701-012-1413-2","volume":"154","author":"P De Bonis","year":"2012","unstructured":"De Bonis P, Anile C, Pompucci A, Fiorentino A, Balducci M, Chiesa S, Maira G, Mangiola A (2012) Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma. Acta Neurochir (Wien) 154:1371\u20131378. https:\/\/doi.org\/10.1007\/s00701-012-1413-2","journal-title":"Acta Neurochir (Wien)"},{"key":"2052_CR17","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1245\/s10434-012-2764-x","volume":"20","author":"J Duntze","year":"2013","unstructured":"Duntze J, Litr\u00e9 C-F, Eap C, Th\u00e9ret E, Debreuve A, Jovenin N, Lechapt-Zalcman E, Metellus P, Colin P, Guillamo J-S, Emery E, Menei P, Rousseaux P, Peruzzi P (2013) Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: prospective, observational, multicenter study on 92 cases. Ann Surg Oncol 20:2065\u20132072. https:\/\/doi.org\/10.1245\/s10434-012-2764-x","journal-title":"Ann Surg Oncol"},{"key":"2052_CR18","doi-asserted-by":"publisher","unstructured":"Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K (2008) Chemotherapeutic wafers for high grade glioma. Cochrane Database Syst Rev CD007294. https:\/\/doi.org\/10.1002\/14651858.CD007294","DOI":"10.1002\/14651858.CD007294"},{"key":"2052_CR19","doi-asserted-by":"publisher","unstructured":"Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K (2011) Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev CD007294. https:\/\/doi.org\/10.1002\/14651858.CD007294.pub2","DOI":"10.1002\/14651858.CD007294.pub2"},{"key":"2052_CR20","doi-asserted-by":"publisher","first-page":"vdab189","DOI":"10.1093\/noajnl\/vdab189","volume":"4","author":"T Iuchi","year":"2022","unstructured":"Iuchi T, Inoue A, Hirose Y, Morioka M, Horiguchi K, Natsume A, Arakawa Y, Iwasaki K, Fujiki M, Kumabe T, Sakata Y (2022) Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. Neuro-Oncol Adv 4:vdab189. https:\/\/doi.org\/10.1093\/noajnl\/vdab189","journal-title":"Neuro-Oncol Adv"},{"key":"2052_CR21","doi-asserted-by":"publisher","first-page":"e0217881","DOI":"10.1371\/journal.pone.0217881","volume":"14","author":"PA Jablonska","year":"2019","unstructured":"Jablonska PA, Diez-Valle R, P\u00e9rez-Larraya JG, Moreno-Jim\u00e9nez M, Idoate M\u00c1, Arbea L, Tejada S, Garcia de Eulate MR, Ramos L, Arbizu J, Dom\u00ednguez P, Aristu JJ (2019) Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PloS One 14:e0217881. https:\/\/doi.org\/10.1371\/journal.pone.0217881","journal-title":"PloS One"},{"key":"2052_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000464464","volume":"93","author":"J Klein","year":"2017","unstructured":"Klein J, Juratli TA, Radev Y, Daubner D, Soucek S, Schackert G, Krex D (2017) Safety and effectiveness of bis-chloroethylnitrosourea wafer chemotherapy in elderly patients with recurrent glioblastoma. Oncology 93:43\u201350. https:\/\/doi.org\/10.1159\/000464464","journal-title":"Oncology"},{"key":"2052_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-006-9303-1","volume":"83","author":"HC Lawson","year":"2007","unstructured":"Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, Weingart J, Kleinberg L, Brem H (2007) Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol 83:61\u201370. https:\/\/doi.org\/10.1007\/s11060-006-9303-1","journal-title":"J Neurooncol"},{"key":"2052_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncol"},{"key":"2052_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/2008.5.17557","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Qui\u00f1ones-Hinojosa A (2009) Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg 110:583\u2013588. https:\/\/doi.org\/10.3171\/2008.5.17557","journal-title":"J Neurosurg"},{"key":"2052_CR26","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1245\/s10434-010-1081-5","volume":"17","author":"P Menei","year":"2010","unstructured":"Menei P, Metellus P, Parot-Schinkel E, Loiseau H, Capelle L, Jacquet G, Guyotat J, Neuro-oncology Club of the French Society of Neurosurgery (2010) Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience. Ann Surg Oncol 17:1740\u20131746. https:\/\/doi.org\/10.1245\/s10434-010-1081-5","journal-title":"Ann Surg Oncol"},{"key":"2052_CR27","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.clineuro.2012.02.056","volume":"114","author":"P Miglierini","year":"2012","unstructured":"Miglierini P, Bouchekoua M, Rousseau B, Hieu PD, Malhaire J-P, Pradier O (2012) Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity. Clin Neurol Neurosurg 114:1222\u20131225. https:\/\/doi.org\/10.1016\/j.clineuro.2012.02.056","journal-title":"Clin Neurol Neurosurg"},{"key":"2052_CR28","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1200\/JCO.2005.04.5963","volume":"24","author":"R-O Mirimanoff","year":"2006","unstructured":"Mirimanoff R-O, Gorlia T, Mason W, Van den Bent MJ, Kortmann R-D, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial. J Clin Oncol Off J Am Soc Clin Oncol 24:2563\u20132569. https:\/\/doi.org\/10.1200\/JCO.2005.04.5963","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2052_CR29","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.3390\/cancers13122911","volume":"13","author":"A Moiraghi","year":"2021","unstructured":"Moiraghi A, Roux A, Peeters S, Pelletier J-B, Baroud M, Trancart B, Oppenheim C, Lechapt E, Benevello C, Parraga E, Varlet P, Chr\u00e9tien F, Dezamis E, Zanello M, Pallud J (2021) Feasibility, safety and impact on overall survival of awake resection for newly diagnosed supratentorial IDH-wildtype glioblastomas in adults. Cancers 13:2911. https:\/\/doi.org\/10.3390\/cancers13122911","journal-title":"Cancers"},{"key":"2052_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6143","author":"AM Molinaro","year":"2020","unstructured":"Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS (2020) Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6143","journal-title":"JAMA Oncol"},{"key":"2052_CR31","volume-title":"NICE guidance on cancer services: improving outcomes for people with brain and other CNS tumours: the manual","author":"National Institute for Health and Clinical Excellence","year":"2006","unstructured":"National Institute for Health and Clinical Excellence (2006) NICE guidance on cancer services: improving outcomes for people with brain and other CNS tumours: the manual. National Institute for Health and Clinical Excellence, London"},{"key":"2052_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3171\/2013.9.JNS13877","volume":"120","author":"A Noorbakhsh","year":"2014","unstructured":"Noorbakhsh A, Tang JA, Marcus LP, McCutcheon B, Gonda DD, Schallhorn CS, Talamini MA, Chang DC, Carter BS, Chen CC (2014) Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg 120:31\u201339. https:\/\/doi.org\/10.3171\/2013.9.JNS13877","journal-title":"J Neurosurg"},{"key":"2052_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/brainsci12050567","volume":"12","author":"T Ohnishi","year":"2022","unstructured":"Ohnishi T, Yamashita D, Inoue A, Suehiro S, Ohue S, Kunieda T (2022) Is interstitial chemotherapy with carmustine (BCNU) wafers effective against local recurrence of glioblastoma? A pharmacokinetic study by measurement of BCNU in the tumor resection cavity. Brain Sci 12:567. https:\/\/doi.org\/10.3390\/brainsci12050567","journal-title":"Brain Sci"},{"key":"2052_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3171\/2011.8.JNS102114","volume":"116","author":"A Oszvald","year":"2012","unstructured":"Oszvald A, G\u00fcresir E, Setzer M, Vatter H, Senft C, Seifert V, Franz K (2012) Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age. J Neurosurg 116:357\u2013364. https:\/\/doi.org\/10.3171\/2011.8.JNS102114","journal-title":"J Neurosurg"},{"key":"2052_CR35","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/neuonc\/nov126","volume":"17","author":"J Pallud","year":"2015","unstructured":"Pallud J, Audureau E, Noel G, Corns R, Lechapt-Zalcman E, Duntze J, Pavlov V, Guyotat J, Hieu PD, Le Reste P-J, Faillot T, Litre C-F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes J-R, Barat J-L, Langlois O, Dezamis E, Parraga E, Zanello M, Nader E, Lefranc M, Bauchet L, Devaux B, Menei P, Metellus P, Club de Neuro-Oncologie of the Soci\u00e9t\u00e9 Fran\u00e7aise de Neurochirurgie (2015) Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort. Neuro-Oncol 17:1609\u20131619. https:\/\/doi.org\/10.1093\/neuonc\/nov126","journal-title":"Neuro-Oncol"},{"key":"2052_CR36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3109\/02688697.2015.1012051","volume":"29","author":"V Pavlov","year":"2015","unstructured":"Pavlov V, Page P, Abi-Lahoud G, Nataf F, Dezamis E, Robin A, Varlet P, Turak B, Dhermain F, Domont J, Louvel G, Souillard-Scemama R, Parraga E, Meder J-F, Chr\u00e9tien F, Devaux B, Pallud J (2015) Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomas. Br J Neurosurg 29:524\u2013531. https:\/\/doi.org\/10.3109\/02688697.2015.1012051","journal-title":"Br J Neurosurg"},{"key":"2052_CR37","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP, Investigators T (2017) Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med 376:1027\u20131037. https:\/\/doi.org\/10.1056\/NEJMoa1611977","journal-title":"N Engl J Med"},{"key":"2052_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2017.07.003","author":"A Roux","year":"2017","unstructured":"Roux A, Caire F, Guyotat J, Menei P, Metellus P, Pallud J, Neuro-Oncology Club of the French Neurosurgical Society (2017) Carmustine wafer implantation for high-grade gliomas: evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery. Neurochirurgie. https:\/\/doi.org\/10.1016\/j.neuchi.2017.07.003","journal-title":"Neurochirurgie"},{"key":"2052_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2551-4","author":"A Roux","year":"2017","unstructured":"Roux A, Peeters S, Zanello M, Bou Nassif R, Abi Lahoud G, Dezamis E, Parraga E, Lechapt-Zalcmann E, Dhermain F, Dumont S, Louvel G, Chretien F, Sauvageon X, Devaux B, Oppenheim C, Pallud J (2017) Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-017-2551-4","journal-title":"J Neurooncol"},{"key":"2052_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00701-013-1931-6","volume":"156","author":"MA Samis Zella","year":"2014","unstructured":"Samis Zella MA, Wallocha M, Slotty PJ, Isik G, H\u00e4nggi D, Schroeteler J, Ewelt C, Steiger H-J, Sabel M (2014) Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma. Acta Neurochir (Wien) 156:313\u2013323. https:\/\/doi.org\/10.1007\/s00701-013-1931-6","journal-title":"Acta Neurochir (Wien)"},{"key":"2052_CR41","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00432-021-03770-9","volume":"148","author":"C Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der C, Gramatzki D, Vu E, Guckenberger M, Andratschke N, Weller M, Hertler C (2022) Radiotherapy for glioblastoma patients with poor performance status. J Cancer Res Clin Oncol 148:2127\u20132136. https:\/\/doi.org\/10.1007\/s00432-021-03770-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"2052_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff R-O, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"2052_CR43","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"2052_CR44","doi-asserted-by":"crossref","unstructured":"Subach BR, Witham TF, Kondziolka D, Lunsford LD, Bozik M, Schiff D (1999) Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery 45:17\u201322; discussion 22\u201323","DOI":"10.1097\/00006123-199907000-00004"},{"key":"2052_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2176\/nmc.52.570","volume":"52","author":"T Uzuka","year":"2012","unstructured":"Uzuka T, Aoki H, Natsumeda M, Takahashi H, Fujii Y (2012) Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute. Neurol Med Chir (Tokyo) 52:570\u2013576","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2052_CR46","doi-asserted-by":"publisher","unstructured":"Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, Van den Bent MJ, Chang SM (2012) Application of novel response\/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery 70:234\u2013243; discussion 243\u2013244. https:\/\/doi.org\/10.1227\/NEU.0b013e318223f5a7","DOI":"10.1227\/NEU.0b013e318223f5a7"},{"key":"2052_CR47","doi-asserted-by":"publisher","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"2052_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1215\/S1522-8517-02-00023-6","volume":"5","author":"M Westphal","year":"2003","unstructured":"Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, J\u00e4\u00e4skel\u00e4inen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncol 5:79\u201388. https:\/\/doi.org\/10.1215\/S1522-8517-02-00023-6","journal-title":"Neuro-Oncol"},{"key":"2052_CR49","doi-asserted-by":"publisher","unstructured":"Westphal M, Ram Z, Riddle V, Hilt D, Bortey E, Executive Committee of the Gliadel Study Group (2006) Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148:269\u2013275; discussion 275. https:\/\/doi.org\/10.1007\/s00701-005-0707-z","DOI":"10.1007\/s00701-005-0707-z"},{"key":"2052_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2573-y","author":"M Zanello","year":"2017","unstructured":"Zanello M, Roux A, Ursu R, Peeters S, Bauchet L, Noel G, Guyotat J, Le Reste P-J, Faillot T, Litre F, Desse N, Emery E, Petit A, Peltier J, Voirin J, Caire F, Barat J-L, Vignes J-R, Menei P, Langlois O, Dezamis E, Carpentier A, Dam Hieu P, Metellus P, Pallud J, On the Behalf of the\u00a0Club de Neuro-Oncologie of the Soci\u00e9t\u00e9 Fran\u00e7aise de Neurochirurgie (2017) Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment? J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-017-2573-y","journal-title":"J Neurooncol"},{"key":"2052_CR51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/nov033","volume":"17","author":"Y Zou","year":"2015","unstructured":"Zou Y, Bai HX, Wang Z, Yang L (2015) Biopsy versus resection in the management of high-grade gliomas in the elderly. Neuro-Oncol 17:901\u2013903. https:\/\/doi.org\/10.1093\/neuonc\/nov033","journal-title":"Neuro-Oncol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02052-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-023-02052-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02052-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T18:08:46Z","timestamp":1705946926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-023-02052-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1007\/s10143-023-02052-x","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,17]]},"assertion":[{"value":"22 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received required authorizations (IRB#12022\/47) from the human research institutional review board (IRB00011687).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement to obtain informed consent was waived according to French legislation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Johan PALLUD and Alexandre ROUX have received honoraria for consultancy from Kyowa Hakko Kirin Co. Johan PALLUD and Alexandre ROUX have received honoraria for speaking engagements (including travel and accommodation) from Kyowa Hakko Kirin Co.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}